Cash Flow Statement

Daily Values

Growth Metrics

Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Interest Coverage Ratio Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Invested Capital (QoQ)Return on Invested Capital Growth (1y)Return on Invested Capital Growth (3y)Return on Invested Capital Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Tax Rate Growth (1y)Tax Rate Growth (3y)Tax Rate Growth (5y)Total Debt (QoQ)Total Debt Growth (1y)Total Debt Growth (3y)

Others

Corcept Therapeutics (CORT) Gross Profit Growth (3y) (2015 - 2026)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Profit Growth (3y) (Qtr)
1	Quantum Biopharma	1,216,509.61 Bn	1,216,509.61 Bn	-	-
2	Alterity Therapeutics	764,224.41 Bn	764,224.38 Bn	-	-
3	Legend Biotech	2,716.00 Bn	2,715.71 Bn	242.10 Mn	411.41%
4	Nanobiotix	2,248.83 Bn	2,248.77 Bn	-	-
5	Akari Therapeutics	1,951.18 Bn	1,951.17 Bn	-	-
6	Vertex Pharmaceuticals	113.69 Bn	106.44 Bn	2.59 Bn	7.16%
7	Evaxion A	64.16 Bn	64.14 Bn	-	-
8	Regeneron Pharmaceuticals	63.94 Bn	55.18 Bn	3.31 Bn	4.34%
9	Alnylam Pharmaceuticals	40.13 Bn	37.12 Bn	959.66 Mn	51.16%
10	Corcept Therapeutics	7.26 Bn	6.92 Bn	162.02 Mn	15.83%

Historic Data

Download Data 🔒

Date	Value
Mar 31, 2026	15.83%
Dec 31, 2025	25.25%
Sep 30, 2025	26.46%
Jun 30, 2025	23.23%
Mar 31, 2025	18.75%
Dec 31, 2024	22.45%
Sep 30, 2024	23.73%
Jun 30, 2024	21.37%
Mar 31, 2024	22.66%
Dec 31, 2023	16.49%
Sep 30, 2023	12.74%
Jun 30, 2023	9.97%
Mar 31, 2023	4.50%
Dec 31, 2022	5.52%
Sep 30, 2022	7.84%
Jun 30, 2022	12.93%
Mar 31, 2022	13.28%
Dec 31, 2021	14.31%
Sep 30, 2021	14.53%
Jun 30, 2021	13.83%
Mar 31, 2021	11.44%
Dec 31, 2020	17.47%
Sep 30, 2020	26.76%
Jun 30, 2020	35.91%
Mar 31, 2020	50.22%
Dec 31, 2019	54.93%
Sep 30, 2019	56.07%
Jun 30, 2019	54.29%
Mar 31, 2019	59.54%
Dec 31, 2018	64.71%
Sep 30, 2018	69.33%
Jun 30, 2018	74.46%
Mar 31, 2018	79.30%
Dec 31, 2017	81.24%
Sep 30, 2017	81.00%
Jun 30, 2017	83.43%
Mar 31, 2017	85.38%
Dec 31, 2016	79.00%
Sep 30, 2016	100.98%
Jun 30, 2016	117.79%
Mar 31, 2016	109.74%
Dec 31, 2015	120.72%
Sep 30, 2015	132.78%
Jun 30, 2015	140.59%